Matthias Ocker

6.7k total citations
161 papers, 5.0k citations indexed

About

Matthias Ocker is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Matthias Ocker has authored 161 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Molecular Biology, 40 papers in Oncology and 34 papers in Epidemiology. Recurrent topics in Matthias Ocker's work include Histone Deacetylase Inhibitors Research (32 papers), Liver Disease Diagnosis and Treatment (21 papers) and Epigenetics and DNA Methylation (17 papers). Matthias Ocker is often cited by papers focused on Histone Deacetylase Inhibitors Research (32 papers), Liver Disease Diagnosis and Treatment (21 papers) and Epigenetics and DNA Methylation (17 papers). Matthias Ocker collaborates with scholars based in Germany, Austria and United States. Matthias Ocker's co-authors include Regine Schneider‐Stock, Daniel Neureiter, Hala Gali‐Muhtasib, Pietro Di Fazio, C. Herold, Marion Ganslmayer, Amr Amin, Karl Quint, Detlef Schuppan and Eckhart G. Hahn and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Matthias Ocker

160 papers receiving 4.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matthias Ocker Germany	39	2.9k	1.1k	626	574	536	161	5.0k
Kodappully Sivaraman Siveen United States	38	2.7k 0.9×	1.2k 1.1×	951 1.5×	263 0.5×	530 1.0×	74	4.7k
Ramzi M. Mohammad United States	41	2.9k 1.0×	1.2k 1.2×	601 1.0×	216 0.4×	534 1.0×	154	4.8k
Shangha Pan China	47	3.0k 1.1×	843 0.8×	1.2k 1.8×	740 1.3×	583 1.1×	121	5.3k
Wei Tang China	38	2.1k 0.7×	945 0.9×	906 1.4×	725 1.3×	253 0.5×	177	4.6k
Zhiyu Li China	43	3.1k 1.1×	974 0.9×	790 1.3×	450 0.8×	305 0.6×	291	6.0k
Yi‐Hsien Hsieh Taiwan	41	3.2k 1.1×	941 0.9×	1.3k 2.0×	441 0.8×	357 0.7×	207	5.3k
Shousong Cao United States	39	2.5k 0.9×	1.3k 1.2×	677 1.1×	240 0.4×	285 0.5×	113	4.7k
Masahiro Kizaki Japan	47	3.1k 1.1×	1.3k 1.2×	422 0.7×	356 0.6×	714 1.3×	230	5.8k
Yih‐Shou Hsieh Taiwan	39	1.8k 0.6×	515 0.5×	794 1.3×	369 0.6×	370 0.7×	124	4.1k
Lingzhi Wang Singapore	45	3.6k 1.3×	1.5k 1.4×	1.8k 2.8×	334 0.6×	411 0.8×	148	6.4k

Countries citing papers authored by Matthias Ocker

Since Specialization

Citations

This map shows the geographic impact of Matthias Ocker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Ocker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Ocker more than expected).

Fields of papers citing papers by Matthias Ocker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthias Ocker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Ocker. The network helps show where Matthias Ocker may publish in the future.

Co-authorship network of co-authors of Matthias Ocker

This figure shows the co-authorship network connecting the top 25 collaborators of Matthias Ocker. A scholar is included among the top collaborators of Matthias Ocker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthias Ocker. Matthias Ocker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Oberhuber, Rupert, et al.. (2025). The importance of preclinical models for cholangiocarcinoma drug discovery. Expert Opinion on Drug Discovery. 20(2). 205–216. 2 indexed citations

Kiesslich, Tobias, Matthias Ocker, Martina Winklmayr, et al.. (2024). The efficacy of ferroptosis-inducing compounds IKE and RSL3 correlates with the expression of ferroptotic pathway regulators CD71 and SLC7A11 in biliary tract cancer cells. PLoS ONE. 19(4). e0302050–e0302050. 4 indexed citations

Ocker, Matthias, Christian Mayr, Sebastian Stintzing, et al.. (2022). Ferroptosis in Hepatocellular Carcinoma: Mechanisms, Drug Targets and Approaches to Clinical Translation. Cancers. 14(7). 1826–1826. 45 indexed citations

Ellinghaus, Peter, Daniel Neureiter, Hendrik Nogai, Sebastian Stintzing, & Matthias Ocker. (2022). Patient Selection Approaches in FGFR Inhibitor Trials—Many Paths to the Same End?. Cells. 11(19). 3180–3180. 14 indexed citations

Roderfeld, M, Anita Windhorst, Diran Herebıan, et al.. (2021). Pharmacologic Antagonization of Cannabinoid Receptor 1 Improves Cholestasis in Abcb4 Mice. Cellular and Molecular Gastroenterology and Hepatology. 13(4). 1041–1055. 6 indexed citations

Cho, Byoung Chul, Grace K. Dy, Ramaswamy Govindan, et al.. (2018). Phase Ib/II study of the pan-cyclin-dependent kinase inhibitor roniciclib in combination with chemotherapy in patients with extensive-disease small-cell lung cancer. Lung Cancer. 123. 14–21. 25 indexed citations

Mayr, Christian, Matthias Ocker, Markus Ritter, et al.. (2017). Biliary tract cancer stem cells - translational options and challenges. World Journal of Gastroenterology. 23(14). 2470–2470. 11 indexed citations

Tanwar, Sudeep, Paul Trembling, Brian Hogan, et al.. (2016). Biomarkers of Hepatic Fibrosis in Chronic Hepatitis C. Journal of Clinical Gastroenterology. 51(3). 268–277. 9 indexed citations

Quint, Karl, Daniel Neureiter, Christopher Nimsky, et al.. (2014). The role of sphingosine kinase isoforms and receptors S1P1, S1P2, S1P3, and S1P5 in primary, secondary, and recurrent glioblastomas. Tumor Biology. 35(9). 8979–8989. 41 indexed citations

10.

Fendrich, Volker, Annette Ramaswamy, Roberta Montalbano, et al.. (2013). Embryonic Transcription Factors CDX2 and Oct4 Are Overexpressed in Neuroendocrine Tumors of the Ileum: A Pilot Study. European Surgical Research. 51(1-2). 14–20. 4 indexed citations

11.

Meggers, Eric, et al.. (2012). PIM1 kinase as a target for cancer therapy. Expert Opinion on Investigational Drugs. 21(4). 425–436. 104 indexed citations

12.

Kemmerling, Ralf, Beate Alinger, Otto Dietze, et al.. (2012). Association of stem cell marker expression pattern and survival in human biliary tract cancer. International Journal of Oncology. 41(2). 511–522. 13 indexed citations

13.

Quint, Karl, Abbas Agaimy, Pietro Di Fazio, et al.. (2011). Clinical significance of histone deacetylases 1, 2, 3, and 7: HDAC2 is an independent predictor of survival in HCC. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 459(2). 129–139. 98 indexed citations

14.

Fazio, Pietro Di, Regine Schneider‐Stock, Daniel Neureiter, et al.. (2010). The Pan-Deacetylase Inhibitor Panobinostat Inhibits Growth of Hepatocellular Carcinoma Models by Alternative Pathways of Apoptosis. SHILAP Revista de lepidopterología. 58 indexed citations

15.

Ocker, Matthias. (2010). Deacetylase inhibitors - focus on non-histone targets and effects. World Journal of Biological Chemistry. 1(5). 55–55. 54 indexed citations

16.

Ocker, Matthias, et al.. (2009). Differential regulation of connective tissue growth factor in renal cells by histone deacetylase inhibitors. Journal of Cellular and Molecular Medicine. 13(8b). 2353–2364. 21 indexed citations

17.

Gali‐Muhtasib, Hala, Doerthe Kuester, Christian Mawrin, et al.. (2008). Thymoquinone Triggers Inactivation of the Stress Response Pathway Sensor CHEK1 and Contributes to Apoptosis in Colorectal Cancer Cells. Cancer Research. 68(14). 5609–5618. 129 indexed citations

18.

Neureiter, Daniel, Ralf Kemmerling, Matthias Ocker, et al.. (2008). Differential diagnostic challenge of chronic neutrophilic leukemia in a patient with prolonged leukocytosis. Journal of Hematopathology. 1(1). 23–27. 4 indexed citations

19.

Gali‐Muhtasib, Hala, Matthias Ocker, Doerthe Kuester, et al.. (2007). Thymoquinone reduces mouse colon tumor cell invasion and inhibits tumor growth in murine colon cancer models. Journal of Cellular and Molecular Medicine. 12(1). 330–342. 136 indexed citations

20.

Neureiter, Daniel, Peter U. Heuschmann, Sebastian Stintzing, et al.. (2003). Detection of Chlamydia pneumoniae but not of Helicobacter pylori in symptomatic atherosclerotic carotids associated with enhanced serum antibodies, inflammation and apoptosis rate. Atherosclerosis. 168(1). 153–162. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact